Q1 2025 · 13F-HR
a16z Capital Management, L.L.C.holdings as filed
Filed 2025-05-15 · accession 0001415889-25-013091
$700.9M
Reported value
13
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 25809K105 | DASH | DOORDASH INC | $291.9M | 41.6% | 1,597,010 | Common | SOLE |
| 79589L106 | IOT | SAMSARA INC | $153.2M | 21.9% | 3,995,652 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $97.2M | 13.9% | 2,748,523 | Common | SOLE |
| 852234103 | XYZ | BLOCK INC | $55.2M | 7.88% | 1,016,697 | Common | SOLE |
| 00437E102 | ACCDUSD | ACCOLADE INC | $37.7M | 5.38% | 5,398,708 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $18.7M | 2.67% | 1,702,225 | Common | SOLE |
| 63909J108 | NAUT | NAUTILUS BIOTECHNOLOGY INC | $15.2M | 2.17% | 17,653,917 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $12.2M | 1.73% | 3,233,170 | Common | SOLE |
| 13463J101 | CAMP | CAMP4 THERAPEUTICS CORP | $8.5M | 1.21% | 2,125,339 | Common | SOLE |
| 683712103 | OPEN | OPENDOOR TECHNOLOGIES INC | $6.3M | 0.90% | 6,200,821 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $3.9M | 0.56% | 2,862,500 | Common | SOLE |
| 37611X209 | DNA | GINKGO BIOWORKS HOLDINGS INC | $618,838 | 0.09% | 108,568 | Common | SOLE |
| 23257B305 | CYN | CYNGN INC | $260,856 | 0.04% | 57,584 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.